Pre-percutaneous coronary intervention statin therapy: Is it necessary?

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064203%3A_____%2F14%3A10292852" target="_blank" >RIV/00064203:_____/14:10292852 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00216208:11130/14:10292852

Výsledek na webu

<a href="http://dx.doi.org/10.1016/j.ahj.2014.06.001" target="_blank" >http://dx.doi.org/10.1016/j.ahj.2014.06.001</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1016/j.ahj.2014.06.001" target="_blank" >10.1016/j.ahj.2014.06.001</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Pre-percutaneous coronary intervention statin therapy: Is it necessary?

Popis výsledku v původním jazyce

I read with interest a study by Kenaan et al concluding that, among 80,493 consecutive, nonemergency percutaneous coronary intervention's (PCI) patients from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium registry, one-third of patientsdid not receive statins before PCI, which had no consequences in terms of major inhospital adverse events or long-term mortality. I wish to support their experience and comment on our randomized studies dealing with this topic. There are several observational and randomized studies demonstrating that both statin-naive patients and patients on chronic statin therapy assigned to pretreatment with statins were associated with a reduced occurrence of myocardial injury or periprocedural myocardial infarction. These findings led to recommendation to use loading or reloading with high-dose statins before PCI. Our first nonrandomized observation suggested that pretreatment with different types of statins in patients undergoing PCI for stable a

Název v anglickém jazyce

Pre-percutaneous coronary intervention statin therapy: Is it necessary?

Popis výsledku anglicky

I read with interest a study by Kenaan et al concluding that, among 80,493 consecutive, nonemergency percutaneous coronary intervention's (PCI) patients from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium registry, one-third of patientsdid not receive statins before PCI, which had no consequences in terms of major inhospital adverse events or long-term mortality. I wish to support their experience and comment on our randomized studies dealing with this topic. There are several observational and randomized studies demonstrating that both statin-naive patients and patients on chronic statin therapy assigned to pretreatment with statins were associated with a reduced occurrence of myocardial injury or periprocedural myocardial infarction. These findings led to recommendation to use loading or reloading with high-dose statins before PCI. Our first nonrandomized observation suggested that pretreatment with different types of statins in patients undergoing PCI for stable a

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FA - Kardiovaskulární nemoci včetně kardiochirurgie

OECD FORD obor

—

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2014

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

American Heart Journal

ISSN

0002-8703

e-ISSN

—

Svazek periodika

168

Číslo periodika v rámci svazku

2

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

1

Strana od-do

—

Kód UT WoS článku

000340207700003

EID výsledku v databázi Scopus

—